FDA considered 8 factors to make its CBD scheduling recommendation, concluding that CBD doesn’t meet the criteria for federal control at all. This post from Marijuana Moment sheds more light on FDA's suggestions. Last week’s decision by the U.S. Drug Enforcement Administration (DEA) to place a marijuana-derived drug in the least restrictive category under federal law was ... Continue Reading
CBD
Cannabis Oil and CBD Oil: You Need to Know the Difference
Cannabis oil can benefit a lot of serious ailments and it’s time to clear the confusion on it. This post from Green Flower highlights the ins and outs of cannabis oil and the difference between CBD oil and cannabis oil. Did you know that the cannabis plant can produce over 400 different chemical compounds? Many of these compounds are expected to have therapeutic potential, ... Continue Reading
CBD As Supplement: Will Mexico Set an Example?
Mexico could make history by treating CBD like a supplement, as it should be. This post from Forbes discusses the impact Mexico can have if it handles its drug policy right. As Mexico transitions to a federal medical marijuana program, lawmakers' leeway toward cannabidiol (CBD) could help the so-called "miracle" compound become as common and low-drama as vitamins and ... Continue Reading
CBD Finally Gets FDA Approval for Rare Epilepsy
In June 2018, a CBD based drug got the FDA approval to treat epileptic seizures. This post from SOL*CBD delves deeper into what led to this decision & what CBD oil can do for the body. A big change is coming to U.S. federal policy on medical marijuana. For well over a year now, despite the opinions from the current administration, the signs coming out of the Food and ... Continue Reading
FDA’s Approval of CBD Drug & Its Impact on Startups
The first CBD-based prescription drug in the US has finally been approved by FDA. This post from Business Insider India highlights why this welcome decision is worrying some marijuana startups. Summary: This week's historic decision by the Food and Drug Administration to approve Epidiolex, the first prescription drug derived from marijuana, has left cannabis startups in ... Continue Reading